APA (7th ed.) Citation

Ameziane, N., Djellali, L., Yamouni, M., Bazzi, A., Yousfi, M. D., Attar, A., & Bousahba, A. (2018). [73] Outcomes of patients with advanced clear-cell renal cell carcinoma treated by sunitinib as first-line therapy: A prospective observational study in real-world practice of the Academic Hospital of Oran, Algeria. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Ameziane, Nadia, Louafi Djellali, Mohamed Yamouni, Ali Bazzi, Mostafa Djamal Yousfi, Abderrahmane Attar, and Abdelkader Bousahba. [73] Outcomes of Patients with Advanced Clear-cell Renal Cell Carcinoma Treated by Sunitinib as First-line Therapy: A Prospective Observational Study in Real-world Practice of the Academic Hospital of Oran, Algeria. Taylor & Francis Group, 2018.

MLA (8th ed.) Citation

Ameziane, Nadia, et al. [73] Outcomes of Patients with Advanced Clear-cell Renal Cell Carcinoma Treated by Sunitinib as First-line Therapy: A Prospective Observational Study in Real-world Practice of the Academic Hospital of Oran, Algeria. Taylor & Francis Group, 2018.